Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...

European pharma giant Roche beat first-quarter sales expectations on Thursday, while drug brethren Sanofi came in with a mixed sales report. But shares of both remained muted.Roche's total sales grew ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump’s ...

The stock’s sentiments have received a significant boost following the approval of the flagship drug Ohtuvayre for the ...

We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going ...

U.S. stock indexes rallied at midday Wednesday as President Donald Trump said he has "no intention" of firing Federal Reserve ...